December 2018 - Page 216 of 313

TSX Venture News - December 10, 2018

Puma Exploration Inc., Votorantim Metals Canada Inc. and Trevali Mining Corporation Amend the Terms of the Murray Brook Property Agreement

RIMOUSKI, Quebec, Dec. 10, 2018 (GLOBE NEWSWIRE) — Puma Exploration Inc. (the “Company” or “Puma”) announces that by mutual agreement, […]

NASDAQ Companies - December 10, 2018

Voyager Therapeutics Announces First Patient Dosed in RESTORE-1, a Phase 2 Trial of VY-AADC Gene Therapy for the Treatment of Parkinson’s Disease

CAMBRIDGE, Mass., Dec. 10, 2018 (GLOBE NEWSWIRE) — Voyager Therapeutics, Inc. (NASDAQ: VYGR), a clinical-stage gene therapy company focused on […]

NASDAQ Companies - December 10, 2018

Resonant Inc. Launches Filter IP Standard Library; Leading Power Amplifier Vendor Licenses First Fast-Track Quadplexer Solution from the Library

Existing fabless customer expands relationship with license agreement GOLETA, Calif., Dec. 10, 2018 (GLOBE NEWSWIRE) — Resonant Inc. (NASDAQ: RESN), […]

TSX News - December 10, 2018

IMV Announces Updated Clinical Data Presentation for Lead Candidate DPX-Survivac’s Phase 1b/2 Immunotherapy Combination Trial at the ESMO Immuno-Oncology Congress 2018

IMV to host an investor call on Thursday, December 13 at 8:30 a.m. ET to discuss the presentation DARTMOUTH, Nova […]

NYSE Companies - December 10, 2018

A. H. Belo Corporation Announces Termination of Agreement to Sell Property

DALLAS, Dec. 10, 2018 (GLOBE NEWSWIRE) — A. H. Belo Corporation (NYSE: AHC) announced today that on December 6, 2018, the […]

NASDAQ Companies - December 10, 2018

Optinose Announces First Patient Enrolled in Clinical Trial of XHANCE for Chronic Sinusitis

Company also announces first patient enrolled in clinical trial of XHANCE for treatment of nasal polyps in pediatric patients YARDLEY, […]

NASDAQ Companies - December 10, 2018

Hamilton Lane Again Named a ‘Best Place to Work’ by both Pensions & Investments and Central Penn Business Journal

Seventh consecutive recognition for both awards BALA CYNWYD, Pa., Dec. 10, 2018 (GLOBE NEWSWIRE) — Hamilton Lane (NASDAQ: HLNE) has […]

NASDAQ Companies - December 10, 2018

Menlo Therapeutics’ Successful Phase 2 Clinical Trial of Serlopitant Demonstrates Reduction of Pruritus Associated with Psoriasis

Company to Conduct Conference Call and Webcast Today at 8:00am ET / 5:00am PT REDWOOD CITY, Calif., Dec. 10, 2018 […]

NASDAQ Companies - December 10, 2018

Axovant Reports Results of Exploratory Phase 2 Clinical Study of Nelotanserin in Lewy Body Dementia Patients Experiencing REM Sleep Behavior Disorder

Primary efficacy endpoint assessed by sleep laboratory video assessment was not met Axovant is discontinuing clinical development of nelotanserin BASEL, […]

NASDAQ Companies - December 10, 2018

Axsome Therapeutics Announces Positive Outcome of Interim Analysis of ADVANCE-1 Phase 2/3 Trial of AXS-05 in Alzheimer’s Disease Agitation

IDMC recommends continuation of trial evaluating AXS-05 versus placebo in Alzheimer’s disease agitation IDMC recommends no further enrollment to single-agent […]